• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

information for practice

news, new scholarship & more from around the world


advanced search
  • gary.holden@nyu.edu
  • @ Info4Practice
  • Archive
  • About
  • Help
  • Browse Key Journals
  • RSS Feeds

Polyunsaturated fatty acid supplementation for schizophrenia

Schizophrenia is a serious mental health problem that affects about one percent of any population. For some people it can become an illness that they have to live with for their entire life. Early research has suggested that supplementing the diet with omega 3 or omega 6 fatty acids may have a positive effect on the symptoms of schizophrenia. This review looks at randomised control trials where omega 3 or omega 6 were used in combination with antipsychotic medication, or as a treatment in their own right for schizophrenia. Eight studies were found which included a total of 517 people who had a diagnosis of schizophrenia or schizoaffective disorder (combined symptoms of schizophrenia and a mood disorder). They ranged from six to 16 weeks in length and were in both hospital and community settings.

Posted in: Meta-analyses - Systematic Reviews on 02/12/2012 | Link to this post on IFP |
Share

Primary Sidebar

Categories

Category RSS Feeds

  • Calls & Consultations
  • Clinical Trials
  • Funding
  • Grey Literature
  • Guidelines Plus
  • History
  • Infographics
  • Journal Article Abstracts
  • Meta-analyses - Systematic Reviews
  • Monographs & Edited Collections
  • News
  • Open Access Journal Articles
  • Podcasts
  • Video

© 1993-2025 Dr. Gary Holden. All rights reserved.

gary.holden@nyu.edu
@Info4Practice